INOZYME PHARMA INC

CUSIP: 45790W108 Class: Common Stock

Bank of New York Mellon Corp's Holding History (CIK: 0001390777)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 155,695 Value ($000) $142 Avg Close — Range —
Q4 2024
Shares 155,695 Value ($000) $431 Avg Close — Range —
Q3 2024
Shares 155,696 Value ($000) $814 Avg Close — Range —
Q2 2024
Shares 190,896 Value ($000) $851 Avg Close — Range —
Q1 2024
Shares 164,432 Value ($000) $1,260 Avg Close — Range —
Q4 2023
Shares 158,015 Value ($000) $673 Avg Close — Range —
Q3 2023
Shares 141,141 Value ($000) $593 Avg Close — Range —
Q2 2023
Shares 141,704 Value ($000) $789 Avg Close — Range —
Q1 2023
Shares 47,165 Value ($000) $270 Avg Close — Range —
Q4 2022
Shares 20,243 Value ($000) $21 Avg Close — Range —
Q3 2022
Shares 20,243 Value ($000) $54 Avg Close — Range —
Q2 2022
Shares 21,898 Value ($000) $105 Avg Close — Range —
Q1 2022
Shares 40,013 Value ($000) $164 Avg Close — Range —
Q4 2021
Shares 41,196 Value ($000) $281 Avg Close — Range —
Q3 2021
Shares 40,418 Value ($000) $469 Avg Close — Range —
Q2 2021
Shares 36,546 Value ($000) $623 Avg Close — Range —
Q1 2021
Shares 23,337 Value ($000) $462 Avg Close — Range —
Q4 2020
Shares 21,349 Value ($000) $440 Avg Close — Range —
Q3 2020
Shares 19,385 Value ($000) $509 Avg Close — Range —